Tag Archives: biomarker

Plasma lncRNA HOTAIR could serve as a promising biomarker for diagnosing and monitoring NSCLC

lncrna

Long noncoding RNA (LncRNA) homeotic genes (HOX) transcript antisense RNA (HOTAIR) has been reported to play a vital role in various cancers. It has been found that HOTAIR was upregulated in non-small cell lung cancer (NSCLC) and involved in cell invasion and metastasis. The aberrant expression of HOTAIR is expected to serve as a potential biomarker for patients with NSCLC. ...

Read More »

Long noncoding RNA expression profile in acute myeloid leukemia identifies a distinct signature and a new biomarker

lncRNA

Long noncoding RNAs are defined as transcripts larger than 200 nucleotides but without protein-coding potential. Cumulative evidence points towards an important role of long noncoding RNAs in cancer initiation, development and progression. In this study researchers from the Cancer Research Center of Toulouse sought to evaluate the long noncoding RNA expression profile of patients with cytogenetically normal acute myeloid leukemia. ...

Read More »

lncRNA SNHG6 is a Potential Biomarker for Hepatocellular Carcinoma

lncRNA

Long Non-coding RNAs (lncRNAs) refer to all non-protein coding transcripts longer than 200 nucleotides. Their critical roles in different biological pathways have been already well established. Altered expression of lncRNAs can be involved in the cancer initiation and/or progression. Since patients with hepatocellular carcinoma (HCC) are usually diagnosed in late stages, developing diagnostic methods seems to be essential. In this ...

Read More »

Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer

lncRNA

Clear cell renal cell carcinomas (ccRCC) show a broad range of clinical behavior, and prognostic biomarkers are needed to stratify patients for appropriate management. Stanford University researchers  sought to determine whether long intergenic non-coding RNAs (lincRNAs) might predict patient survival. Candidate prognostic lincRNAs were identified by mining The Cancer Genome Atlas (TCGA) transcriptome (RNA-seq) data on 466 ccRCC cases (randomized ...

Read More »

Potential of Long Non-coding RNAs in Cancer Patients: From Bio-markers to Therapeutic Targets

lncRNA

Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non-coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a bio-marker in the diagnosis and prognosis of bladder cancer, prostate cancer, gastric cancer, pancreatic cancer, breast cancer, and many other cancer types. Some ...

Read More »

Long noncoding RNA PVT1 may be a novel noninvasive biomarker for early diagnosis of cervical cancer

lncRNA

Eighty-eight cervical cancer patients, 64 cervical intraepithelial neoplasia patients, 25 breast cancer patients, 25 ovarian cancer patients, and 111 healthy control subjects were enrolled into this study. Researchers at Jiangxi University of Traditional Chinese Medicine measured PVT1 serum level in these participants and PVT1 expression in 20 pairs of cervical cancer tissues and adjacent paired normal tissues by quantitative reverse ...

Read More »

Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer

Cancer-secreted long non-coding RNAs (lncRNAs) are emerging mediators of cancer-host cross talk. Researchers at Shandong University aimed to illustrate the clinical significance of the lncRNA CRNDE-h in exosomes purified from the serum of patients with colorectal cancer (CRC). The study was divided into four parts: The exosome isolated methods and lncRNA detected methods which accurately and reproducibly measure CRC-related exosomal ...

Read More »

Long non-coding RNA colon cancer-associated transcript 2 (CCAT2) may function as a potential biomarker for glioma

lncRNA

Long non-coding RNA colon cancer-associated transcript 2 (CCAT2) is commonly investigated in a number of cancers. However, little is known of its expression and biological function in glioma biology. In the current study, researchers from Nanchang University used quantitative real-time PCR (qRT-PCR) to determine the expression of CCAT2 in glioma tissues. They found that expression of CCAT2 was up-regulated in glioma ...

Read More »

Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer

lncRNA

Long intergenic non-protein coding RNA, p53 induced transcript (Linc-pint) is a long noncoding RNA (lncRNA) that regulates tumor cell viability and proliferation. Researchers from Harbin Medical University used qRT-PCR and RNA FISH analysis to evaluate Linc-pint levels in the plasma and tumor tissues of pancreatic cancer (PCa) patients. Their data demonstrate that Linc-pint expression is lower in plasma samples from ...

Read More »

Dysregulation of long non-coding RNA in breast cancer

lncRNA

Long non-coding RNAs (lncRNAs), which occupy nearly 98% of genome, have crucial roles in cancer development, including breast cancer. Breast cancer is a disease with high incidence. Despite of recent progress in understanding the molecular mechanisms and combined therapy strategies, the functions and mechanisms of lncRNAs in breast cancer remains unclear. Researchers from Zhejiang University review the currently basic knowledge ...

Read More »